Td Private Client Wealth LLC Gilead Sciences, Inc. Transaction History
Td Private Client Wealth LLC
- $4.07 Trillion
- Q2 2025
A detailed history of Td Private Client Wealth LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 44,656 shares of GILD stock, worth $5.19 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
44,656
Previous 45,225
1.26%
Holding current value
$5.19 Million
Previous $5.07 Billion
2.3%
% of portfolio
0.12%
Previous 0.14%
Shares
23 transactions
Others Institutions Holding GILD
# of Institutions
2,294Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$14 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.92 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.35 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.22 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $146B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...